nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Nystagmus—Vincristine—sarcoma	0.031	0.0319	CcSEcCtD
Methocarbamol—Carvedilol—VEGFA—sarcoma	0.0287	1	CrCbGaD
Methocarbamol—Nystagmus—Epirubicin—sarcoma	0.0141	0.0145	CcSEcCtD
Methocarbamol—Jaundice—Thiotepa—sarcoma	0.0136	0.014	CcSEcCtD
Methocarbamol—Conjunctivitis—Thiotepa—sarcoma	0.0136	0.014	CcSEcCtD
Methocarbamol—Nystagmus—Doxorubicin—sarcoma	0.013	0.0134	CcSEcCtD
Methocarbamol—Drowsiness—Mitoxantrone—sarcoma	0.0121	0.0124	CcSEcCtD
Methocarbamol—Jaundice—Mitoxantrone—sarcoma	0.0118	0.0121	CcSEcCtD
Methocarbamol—Conjunctivitis—Mitoxantrone—sarcoma	0.0117	0.0121	CcSEcCtD
Methocarbamol—Flushing—Dactinomycin—sarcoma	0.0116	0.0119	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Epirubicin—sarcoma	0.0114	0.0118	CcSEcCtD
Methocarbamol—Bradycardia—Mitoxantrone—sarcoma	0.011	0.0114	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Doxorubicin—sarcoma	0.0106	0.0109	CcSEcCtD
Methocarbamol—Vision blurred—Thiotepa—sarcoma	0.0103	0.0106	CcSEcCtD
Methocarbamol—Coordination abnormal—Epirubicin—sarcoma	0.0102	0.0105	CcSEcCtD
Methocarbamol—Jaundice—Etoposide—sarcoma	0.00978	0.0101	CcSEcCtD
Methocarbamol—Leukopenia—Thiotepa—sarcoma	0.00977	0.0101	CcSEcCtD
Methocarbamol—Leukopenia—Dactinomycin—sarcoma	0.0097	0.00998	CcSEcCtD
Methocarbamol—Coordination abnormal—Doxorubicin—sarcoma	0.00947	0.00975	CcSEcCtD
Methocarbamol—Convulsion—Thiotepa—sarcoma	0.00946	0.00974	CcSEcCtD
Methocarbamol—Dysgeusia—Mitoxantrone—sarcoma	0.00923	0.0095	CcSEcCtD
Methocarbamol—Confusional state—Thiotepa—sarcoma	0.00898	0.00925	CcSEcCtD
Methocarbamol—Vision blurred—Mitoxantrone—sarcoma	0.00888	0.00915	CcSEcCtD
Methocarbamol—Vertigo—Vincristine—sarcoma	0.0087	0.00895	CcSEcCtD
Methocarbamol—Leukopenia—Vincristine—sarcoma	0.00867	0.00892	CcSEcCtD
Methocarbamol—Leukopenia—Mitoxantrone—sarcoma	0.00844	0.00869	CcSEcCtD
Methocarbamol—Thrombophlebitis—Epirubicin—sarcoma	0.00843	0.00868	CcSEcCtD
Methocarbamol—Convulsion—Vincristine—sarcoma	0.00839	0.00864	CcSEcCtD
Methocarbamol—Flushing—Etoposide—sarcoma	0.00836	0.00861	CcSEcCtD
Methocarbamol—Convulsion—Mitoxantrone—sarcoma	0.00817	0.00841	CcSEcCtD
Methocarbamol—Somnolence—Thiotepa—sarcoma	0.00792	0.00815	CcSEcCtD
Methocarbamol—Anaphylactic shock—Vincristine—sarcoma	0.0079	0.00813	CcSEcCtD
Methocarbamol—Dyspepsia—Thiotepa—sarcoma	0.00784	0.00807	CcSEcCtD
Methocarbamol—Thrombophlebitis—Doxorubicin—sarcoma	0.0078	0.00803	CcSEcCtD
Methocarbamol—Confusional state—Mitoxantrone—sarcoma	0.00776	0.00799	CcSEcCtD
Methocarbamol—Anaphylactic shock—Mitoxantrone—sarcoma	0.00769	0.00792	CcSEcCtD
Methocarbamol—Dysgeusia—Etoposide—sarcoma	0.00768	0.00791	CcSEcCtD
Methocarbamol—Pain—Thiotepa—sarcoma	0.00762	0.00784	CcSEcCtD
Methocarbamol—Shock—Mitoxantrone—sarcoma	0.00757	0.00779	CcSEcCtD
Methocarbamol—Pain—Dactinomycin—sarcoma	0.00756	0.00779	CcSEcCtD
Methocarbamol—Hypotension—Vincristine—sarcoma	0.00738	0.0076	CcSEcCtD
Methocarbamol—Feeling abnormal—Thiotepa—sarcoma	0.00734	0.00756	CcSEcCtD
Methocarbamol—Diplopia—Epirubicin—sarcoma	0.0073	0.00751	CcSEcCtD
Methocarbamol—Feeling abnormal—Dactinomycin—sarcoma	0.00729	0.0075	CcSEcCtD
Methocarbamol—Hypotension—Mitoxantrone—sarcoma	0.00719	0.0074	CcSEcCtD
Methocarbamol—Insomnia—Vincristine—sarcoma	0.00715	0.00736	CcSEcCtD
Methocarbamol—Urticaria—Thiotepa—sarcoma	0.00708	0.00729	CcSEcCtD
Methocarbamol—Vertigo—Etoposide—sarcoma	0.00705	0.00725	CcSEcCtD
Methocarbamol—Body temperature increased—Thiotepa—sarcoma	0.00704	0.00725	CcSEcCtD
Methocarbamol—Leukopenia—Etoposide—sarcoma	0.00702	0.00723	CcSEcCtD
Methocarbamol—Body temperature increased—Dactinomycin—sarcoma	0.00699	0.0072	CcSEcCtD
Methocarbamol—Loss of consciousness—Etoposide—sarcoma	0.00689	0.0071	CcSEcCtD
Methocarbamol—Somnolence—Mitoxantrone—sarcoma	0.00684	0.00704	CcSEcCtD
Methocarbamol—Convulsion—Etoposide—sarcoma	0.00679	0.00699	CcSEcCtD
Methocarbamol—Dyspepsia—Mitoxantrone—sarcoma	0.00677	0.00697	CcSEcCtD
Methocarbamol—Pain—Vincristine—sarcoma	0.00676	0.00696	CcSEcCtD
Methocarbamol—Diplopia—Doxorubicin—sarcoma	0.00675	0.00695	CcSEcCtD
Methocarbamol—Pain—Mitoxantrone—sarcoma	0.00658	0.00677	CcSEcCtD
Methocarbamol—Hypersensitivity—Thiotepa—sarcoma	0.00656	0.00676	CcSEcCtD
Methocarbamol—Hypersensitivity—Dactinomycin—sarcoma	0.00651	0.00671	CcSEcCtD
Methocarbamol—Confusional state—Etoposide—sarcoma	0.00645	0.00664	CcSEcCtD
Methocarbamol—Anaphylactic shock—Etoposide—sarcoma	0.0064	0.00659	CcSEcCtD
Methocarbamol—Feeling abnormal—Mitoxantrone—sarcoma	0.00634	0.00653	CcSEcCtD
Methocarbamol—Pruritus—Thiotepa—sarcoma	0.0063	0.00649	CcSEcCtD
Methocarbamol—Body temperature increased—Vincristine—sarcoma	0.00625	0.00643	CcSEcCtD
Methocarbamol—Urticaria—Mitoxantrone—sarcoma	0.00611	0.00629	CcSEcCtD
Methocarbamol—Body temperature increased—Mitoxantrone—sarcoma	0.00608	0.00626	CcSEcCtD
Methocarbamol—Hypotension—Etoposide—sarcoma	0.00598	0.00616	CcSEcCtD
Methocarbamol—Dizziness—Thiotepa—sarcoma	0.00589	0.00607	CcSEcCtD
Methocarbamol—Hypersensitivity—Vincristine—sarcoma	0.00582	0.00599	CcSEcCtD
Methocarbamol—Somnolence—Etoposide—sarcoma	0.00569	0.00586	CcSEcCtD
Methocarbamol—Hypersensitivity—Mitoxantrone—sarcoma	0.00567	0.00584	CcSEcCtD
Methocarbamol—Vomiting—Thiotepa—sarcoma	0.00566	0.00583	CcSEcCtD
Methocarbamol—Drowsiness—Epirubicin—sarcoma	0.00562	0.00579	CcSEcCtD
Methocarbamol—Vomiting—Dactinomycin—sarcoma	0.00562	0.00579	CcSEcCtD
Methocarbamol—Rash—Thiotepa—sarcoma	0.00562	0.00578	CcSEcCtD
Methocarbamol—Dermatitis—Thiotepa—sarcoma	0.00561	0.00578	CcSEcCtD
Methocarbamol—Headache—Thiotepa—sarcoma	0.00558	0.00575	CcSEcCtD
Methocarbamol—Rash—Dactinomycin—sarcoma	0.00558	0.00574	CcSEcCtD
Methocarbamol—Jaundice—Epirubicin—sarcoma	0.00548	0.00564	CcSEcCtD
Methocarbamol—Pain—Etoposide—sarcoma	0.00547	0.00563	CcSEcCtD
Methocarbamol—Conjunctivitis—Epirubicin—sarcoma	0.00547	0.00563	CcSEcCtD
Methocarbamol—Nausea—Thiotepa—sarcoma	0.00529	0.00545	CcSEcCtD
Methocarbamol—Feeling abnormal—Etoposide—sarcoma	0.00527	0.00543	CcSEcCtD
Methocarbamol—Nausea—Dactinomycin—sarcoma	0.00525	0.00541	CcSEcCtD
Methocarbamol—Dizziness—Vincristine—sarcoma	0.00522	0.00538	CcSEcCtD
Methocarbamol—Drowsiness—Doxorubicin—sarcoma	0.0052	0.00536	CcSEcCtD
Methocarbamol—Bradycardia—Epirubicin—sarcoma	0.00514	0.00529	CcSEcCtD
Methocarbamol—Urticaria—Etoposide—sarcoma	0.00508	0.00523	CcSEcCtD
Methocarbamol—Jaundice—Doxorubicin—sarcoma	0.00507	0.00522	CcSEcCtD
Methocarbamol—Body temperature increased—Etoposide—sarcoma	0.00506	0.00521	CcSEcCtD
Methocarbamol—Conjunctivitis—Doxorubicin—sarcoma	0.00506	0.00521	CcSEcCtD
Methocarbamol—Vomiting—Vincristine—sarcoma	0.00502	0.00517	CcSEcCtD
Methocarbamol—Rash—Vincristine—sarcoma	0.00498	0.00513	CcSEcCtD
Methocarbamol—Dermatitis—Vincristine—sarcoma	0.00498	0.00512	CcSEcCtD
Methocarbamol—Headache—Vincristine—sarcoma	0.00495	0.0051	CcSEcCtD
Methocarbamol—Vomiting—Mitoxantrone—sarcoma	0.00489	0.00504	CcSEcCtD
Methocarbamol—Rash—Mitoxantrone—sarcoma	0.00485	0.00499	CcSEcCtD
Methocarbamol—Dermatitis—Mitoxantrone—sarcoma	0.00485	0.00499	CcSEcCtD
Methocarbamol—Headache—Mitoxantrone—sarcoma	0.00482	0.00496	CcSEcCtD
Methocarbamol—Bradycardia—Doxorubicin—sarcoma	0.00476	0.0049	CcSEcCtD
Methocarbamol—Hypersensitivity—Etoposide—sarcoma	0.00472	0.00485	CcSEcCtD
Methocarbamol—Nausea—Vincristine—sarcoma	0.00469	0.00483	CcSEcCtD
Methocarbamol—Flushing—Epirubicin—sarcoma	0.00469	0.00482	CcSEcCtD
Methocarbamol—Nausea—Mitoxantrone—sarcoma	0.00457	0.00471	CcSEcCtD
Methocarbamol—Pruritus—Etoposide—sarcoma	0.00453	0.00466	CcSEcCtD
Methocarbamol—Flushing—Doxorubicin—sarcoma	0.00434	0.00446	CcSEcCtD
Methocarbamol—Dysgeusia—Epirubicin—sarcoma	0.0043	0.00443	CcSEcCtD
Methocarbamol—Dizziness—Etoposide—sarcoma	0.00423	0.00436	CcSEcCtD
Methocarbamol—Vision blurred—Epirubicin—sarcoma	0.00414	0.00427	CcSEcCtD
Methocarbamol—Vomiting—Etoposide—sarcoma	0.00407	0.00419	CcSEcCtD
Methocarbamol—Rash—Etoposide—sarcoma	0.00404	0.00415	CcSEcCtD
Methocarbamol—Dermatitis—Etoposide—sarcoma	0.00403	0.00415	CcSEcCtD
Methocarbamol—Headache—Etoposide—sarcoma	0.00401	0.00413	CcSEcCtD
Methocarbamol—Dysgeusia—Doxorubicin—sarcoma	0.00398	0.0041	CcSEcCtD
Methocarbamol—Vertigo—Epirubicin—sarcoma	0.00395	0.00407	CcSEcCtD
Methocarbamol—Syncope—Epirubicin—sarcoma	0.00394	0.00406	CcSEcCtD
Methocarbamol—Leukopenia—Epirubicin—sarcoma	0.00393	0.00405	CcSEcCtD
Methocarbamol—Loss of consciousness—Epirubicin—sarcoma	0.00386	0.00398	CcSEcCtD
Methocarbamol—Vision blurred—Doxorubicin—sarcoma	0.00383	0.00395	CcSEcCtD
Methocarbamol—Convulsion—Epirubicin—sarcoma	0.00381	0.00392	CcSEcCtD
Methocarbamol—Nausea—Etoposide—sarcoma	0.0038	0.00391	CcSEcCtD
Methocarbamol—Vertigo—Doxorubicin—sarcoma	0.00365	0.00376	CcSEcCtD
Methocarbamol—Syncope—Doxorubicin—sarcoma	0.00365	0.00376	CcSEcCtD
Methocarbamol—Leukopenia—Doxorubicin—sarcoma	0.00364	0.00375	CcSEcCtD
Methocarbamol—Confusional state—Epirubicin—sarcoma	0.00362	0.00372	CcSEcCtD
Methocarbamol—Anaphylactic shock—Epirubicin—sarcoma	0.00359	0.00369	CcSEcCtD
Methocarbamol—Loss of consciousness—Doxorubicin—sarcoma	0.00357	0.00368	CcSEcCtD
Methocarbamol—Shock—Epirubicin—sarcoma	0.00353	0.00363	CcSEcCtD
Methocarbamol—Convulsion—Doxorubicin—sarcoma	0.00352	0.00363	CcSEcCtD
Methocarbamol—Hypotension—Epirubicin—sarcoma	0.00335	0.00345	CcSEcCtD
Methocarbamol—Confusional state—Doxorubicin—sarcoma	0.00335	0.00345	CcSEcCtD
Methocarbamol—Anaphylactic shock—Doxorubicin—sarcoma	0.00332	0.00342	CcSEcCtD
Methocarbamol—Shock—Doxorubicin—sarcoma	0.00327	0.00336	CcSEcCtD
Methocarbamol—Insomnia—Epirubicin—sarcoma	0.00324	0.00334	CcSEcCtD
Methocarbamol—Somnolence—Epirubicin—sarcoma	0.00319	0.00328	CcSEcCtD
Methocarbamol—Dyspepsia—Epirubicin—sarcoma	0.00316	0.00325	CcSEcCtD
Methocarbamol—Hypotension—Doxorubicin—sarcoma	0.0031	0.00319	CcSEcCtD
Methocarbamol—Pain—Epirubicin—sarcoma	0.00307	0.00316	CcSEcCtD
Methocarbamol—Insomnia—Doxorubicin—sarcoma	0.003	0.00309	CcSEcCtD
Methocarbamol—Feeling abnormal—Epirubicin—sarcoma	0.00296	0.00304	CcSEcCtD
Methocarbamol—Somnolence—Doxorubicin—sarcoma	0.00295	0.00304	CcSEcCtD
Methocarbamol—Dyspepsia—Doxorubicin—sarcoma	0.00292	0.00301	CcSEcCtD
Methocarbamol—Urticaria—Epirubicin—sarcoma	0.00285	0.00293	CcSEcCtD
Methocarbamol—Pain—Doxorubicin—sarcoma	0.00284	0.00292	CcSEcCtD
Methocarbamol—Body temperature increased—Epirubicin—sarcoma	0.00284	0.00292	CcSEcCtD
Methocarbamol—Feeling abnormal—Doxorubicin—sarcoma	0.00274	0.00282	CcSEcCtD
Methocarbamol—Hypersensitivity—Epirubicin—sarcoma	0.00264	0.00272	CcSEcCtD
Methocarbamol—Urticaria—Doxorubicin—sarcoma	0.00264	0.00271	CcSEcCtD
Methocarbamol—Body temperature increased—Doxorubicin—sarcoma	0.00262	0.0027	CcSEcCtD
Methocarbamol—Pruritus—Epirubicin—sarcoma	0.00254	0.00261	CcSEcCtD
Methocarbamol—Hypersensitivity—Doxorubicin—sarcoma	0.00245	0.00252	CcSEcCtD
Methocarbamol—Dizziness—Epirubicin—sarcoma	0.00237	0.00244	CcSEcCtD
Methocarbamol—Pruritus—Doxorubicin—sarcoma	0.00235	0.00242	CcSEcCtD
Methocarbamol—Vomiting—Epirubicin—sarcoma	0.00228	0.00235	CcSEcCtD
Methocarbamol—Rash—Epirubicin—sarcoma	0.00226	0.00233	CcSEcCtD
Methocarbamol—Dermatitis—Epirubicin—sarcoma	0.00226	0.00233	CcSEcCtD
Methocarbamol—Headache—Epirubicin—sarcoma	0.00225	0.00231	CcSEcCtD
Methocarbamol—Dizziness—Doxorubicin—sarcoma	0.0022	0.00226	CcSEcCtD
Methocarbamol—Nausea—Epirubicin—sarcoma	0.00213	0.00219	CcSEcCtD
Methocarbamol—Vomiting—Doxorubicin—sarcoma	0.00211	0.00217	CcSEcCtD
Methocarbamol—Rash—Doxorubicin—sarcoma	0.00209	0.00215	CcSEcCtD
Methocarbamol—Dermatitis—Doxorubicin—sarcoma	0.00209	0.00215	CcSEcCtD
Methocarbamol—Headache—Doxorubicin—sarcoma	0.00208	0.00214	CcSEcCtD
Methocarbamol—Nausea—Doxorubicin—sarcoma	0.00197	0.00203	CcSEcCtD
